Notice by the General Office of the China Banking and Insurance Regulatory Commission of Matters Concerning the Investment of Insurance Funds in Debt-to-Equity Swap Investment Plans | | 中国银保监会办公厅关于保险资金投资债转股投资计划有关事项的通知 |
(No. 82 [2020] of the General Office of the China Banking and Insurance Regulatory Commission) | | (银保监办发〔2020〕82号) |
All insurance group (holding) companies, insurance companies, and insurance assets management companies: | | 各保险集团(控股)公司、保险公司、保险资产管理公司: |
For the purposes of enhancing the quality and efficiency of services for the real economy, and optimizing insurance asset allocation structure, under the principle of being market-oriented and law-based and in accordance with the Measures for the Administration of the Utilization of Insurance Funds (Order No. 1 [2018], CIRC) and other provisions, and with the approval of the China Banking and Insurance Regulatory Commission (“CBIRC”), you are hereby notified of matters concerning the investment of insurance funds in debt-to-equity swap investment plans as follows: | | 为提升服务实体经济质效,优化保险资产配置结构,按照市场化法治化原则,根据《保险资金运用管理办法》(中国保险监督管理委员会令2018年第1号)等规定,经银保监会同意,现就保险资金投资债转股投资计划有关事项通知如下: |
I. Insurance funds may be invested in the debt-to-equity swap investment plans established by financial asset investment companies, and shall be governed by the Notice of the Investment of Insurance Funds in the Relevant Financial Products (No. 91 [2012], CIRC). ...... | | 一、保险资金可以投资金融资产投资公司设立的债转股投资计划,纳入《关于保险资金投资有关金融产品的通知》(保监发〔2012〕91号)管理。 ...... |
|
Dear visitor, as a premium member of this database, you will get complete access to all content.Please go premium and get more.
1. To become a premium member, please call 400-810-8266 Ext. 171.
2. Binding to the account with access to this database.
3. Apply for a trial account.
4. To get instant access to a document, you can Pay Amount 【¥200.00】 for your single purchase. | | 您好:您现在要进入的是北大法宝英文库会员专区。 如您是我们英文用户可直接 登录,进入会员专区查询您所需要的信息;如您还不是我们 的英文用户;您可通过网上支付进行单篇购买,支付成功后即可立即查看本篇内容。 Tel: +86 (10) 82689699, +86 (10) 82668266 ext. 153 Mobile: +86 13311570713 Fax: +86 (10) 82668268 E-mail:info@chinalawinfo.com |
| | |
| | |